The diagnostic accuracy of the biomarker panel was 0.85 for MetS(+) HCC patients and 0.92 for MetS(+) CRC & GC patients, which were higher than that of AFP as well (Figure 6C). This evidence concerns the gene AFP and metabolic syndrome.